Nestlé is bringing Sinergity, the innovative infant nutrition product developed based on over thirty years of scientific research, globally. Following its success in Europe, the launch continues in Latin America and the Middle East, with new introductions planned in Asia by the end of 2025.
Marketed under the brand name NAN, Sinergity is a proprietary blend that combines probiotics with six human milk oligosaccharides (HMO), identical to those naturally present in breast milk. This formula helps promote a healthy gut microbiota and strengthen the immune system in the early years of life.
“With Sinergity, Nestlé continues to lead the way in science-based innovation in infant nutrition,” said Laurent Alsteens, global head of Early Childhood Nutrition. “Our HMO products are already available in more than 50 countries and meet growing parental demand for effective and safe solutions.”
Sinergity is one of Nestlé's six strategic big bets for 2025, considered a growth engine with strong potential. The company expects sustained expansion thanks to evolving consumer needs and the consolidated trust in the NAN brand.
